Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)

<p>A new randomized trial suggests that the efficacy of antidepressants for the treatment of bipolar depression is no greater than placebo. This tips the meta-analytic balance scale, which already pointed in this direction.</p> <p>Faculty: Jim Phelps, M.D.<br /> Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC111"> <strong>Learn more about Premium Memberships here</strong></a></li> <li><strong><a href= "https://psychopharmacologyinstitute.com/publication/quick-take-vol-26-2580?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC111"> Earn 0.5 CMEs: Quick Take Vol. 26</a></strong></li> <li><a href= "https://psychopharmacologyinstitute.com/section/citalopram-for-acute-and-preventive-efficacy-in-bipolar-depression-cape-bd-a-randomized-double-blind-placebo-controlled-trial-2580-5033?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC111"> <strong>Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD): A Randomized, Double-Blind, Placebo-Controlled Trial</strong></a></li> </ul>